Cargando…

c-erbB-2 expression in benign and malignant breast disease.

An antibody, 21N, raised against a synthetic peptide from the predicted sequence of the c-erbB-2 protein has been used immunocytochemically in a retrospective study of formalin fixed paraffin embedded breast biopsies. Fourteen out of 103 infiltrating ductal carcinomas exhibited positive membrane sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gusterson, B. A., Machin, L. G., Gullick, W. J., Gibbs, N. M., Powles, T. J., Elliott, C., Ashley, S., Monaghan, P., Harrison, S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246778/ https://www.ncbi.nlm.nih.gov/pubmed/2849975

Ejemplares similares

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.
por: Gullick, W. J., et al.
Publicado: (1991)

c-erbB-4 protein expression in human breast cancer
por: Kew, T Y, et al.
Publicado: (2000)

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
por: Lovekin, C., et al.
Publicado: (1991)

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.
por: Barnes, D. M., et al.
Publicado: (1988)

Pattern of expression of c-erbB-2 oncoprotein in human fetuses.
por: Quirke, P., et al.
Publicado: (1989)

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.
por: Walker, R. A., et al.
Publicado: (1989)

A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.
por: Rajkumar, T., et al.
Publicado: (1994)

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
por: Aasland, R., et al.
Publicado: (1988)

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?
por: Murphy, ML, et al.
Publicado: (2008)

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
por: Travis, A., et al.
Publicado: (1996)

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?
por: Murphy, ML, et al.
Publicado: (2006)

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2018)

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2016)

A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.
por: Parkes, H. C., et al.
Publicado: (1990)

Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
por: Lemoine, N. R., et al.
Publicado: (1991)

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
por: Colomer, R., et al.
Publicado: (1994)

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
por: Ueno, Sho, et al.
Publicado: (2020)

DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells
por: Bi, Yanli, et al.
Publicado: (2021)

Proteolytic Processing of ErbB4 in Breast Cancer
por: Hollmén, Maija, et al.
Publicado: (2012)

Expression of c-erbB3 protein in primary breast carcinomas.
por: Naidu, R., et al.
Publicado: (1998)

c-erbB-2 oncogene as a prognostic marker in breast cancer.
por: Perren, T. J.
Publicado: (1991)

Mutational Screening in Tyrosine-Kinase Domain of erbB1 And erbB2 Genes
por: ALONSO, Juan Manuel Fernández
Publicado: (2005)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
por: Pandya, K, et al.
Publicado: (2011)

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
por: Hubbard, A. L., et al.
Publicado: (1994)

Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010)

Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3
por: Young, Christian D, et al.
Publicado: (2008)

Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
por: Yao, Yong-Liang, et al.
Publicado: (2013)

c-erbB-3 protein expression in ovarian tumours.
por: Simpson, B. J., et al.
Publicado: (1995)

ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases
por: Filippi, Alexandru, et al.
Publicado: (2017)

The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
por: Benlimame, Naciba, et al.
Publicado: (2005)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli, Meysam, et al.
Publicado: (2019)

The long term prognostic significance of c-erbB-2 in primary breast cancer.
por: Winstanley, J., et al.
Publicado: (1991)

Essential function for ErbB3 in breast cancer proliferation
por: Perez-Nadales, Elena, et al.
Publicado: (2004)

Treatment of ErbB2 breast cancer by mitochondrial targeting
por: Eldad, Sophia, et al.
Publicado: (2020)

Expression of MIF and c-erbB-2 in endometrial cancer
por: XIAO, WEI, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gtjra9mr1rmvhipe92632fp02g